No Data
Biotech Bankruptcies Hit a Record Despite Sector's Recovery
Reported Earlier, Scilex Announces Move To Extend Lockup Period For Sorrento-Distributed Dividend Shares Until September 2024
- Scilex Holding Company (NASDAQ:SCLX, " Scilex" ))))), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatm
Sorrento Faked Venue in Bankruptcy Filing, Justice Department Says
Overview of Sorrento Therapeutics' RTX (MCP-101, Resiniferatoxin) Drug Across the 7MM, 2023-2032
Scilex Seeks Health Canada Approval for Migraine Therapy
Virpax Pharmaceuticals Gets Non-compliance Notice From Nasdaq